✦ LIBER ✦

PMS42 Cost-Utility of Tocilizumab Monotherapy in Methotrexate Intolerant/Contra-Indicated, Moderate/Severe Rheumatoid Arthritis Patients in Portugal

✍ Scribed by I. Monteiro; A. Cafe; R. Encarnação; A. Diamantopoulos; F. Dejonckheere

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of tocilizumab monotherapy ve

✍ Jones, G; Sebba, A; Gu, J; Lowenstein, M B; Calvo, A; Gomez-Reino, J J; Siri, D 📂 Article 📅 2009 🏛 BMJ Publishing Group 🌐 English ⚖ 332 KB

PMS30 Cost-Effectiveness of Tocilizumab

✍ A. Diamantopoulos; S. Andrade; A. Bernardo; J. Branco; L. Inês; J.A. Pereira da 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS45 Cost-Utility and Budget Impact Ana

✍ N. Maniadakis; D. Boumpas; G. Kourlaba; P. Christou; I. Anargiros; E. Smets; O P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS29 CANADIAN COST-EFFECTIVENESS ANALYS

✍ D Zou; O Desjardins; N Tsao; R Goeree 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PMS33 COST EFFECTIVENESS OF ABATACEPT IN

✍ F. Becerra Rojas; C. Benites Chacaltana; E.C. Aiello; C. Zingoni; G. Bergman; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB